The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and dry eye disease: Potential association with stress-related disorders (depression/anxiety)

被引:0
|
作者
Hallak, Joelle [1 ]
Gao, Xiaoyi [2 ]
Jain, Sandeep [1 ]
机构
[1] Univ Illinois, IEEI, Dept Ophthalmol & Visual Sci, Corneal Neurobiol Lab, Chicago, IL USA
[2] Univ Illinois, IEEI, Ophthalmol & Visual Sci, Quantitat Ocular Genom Lab, Chicago, IL USA
关键词
486 cornea: tears/tear film/dry eye;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3687
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Association of the Val66Met polymorphism of the brain-derived neurotrophic factor gene with schizophrenia in Russians
    V. E. Golimbet
    G. I. Korovaitseva
    L. I. Abramova
    S. V. Kasparov
    L. G. Uvarova
    [J]. Molecular Biology, 2008, 42 : 531 - 535
  • [22] Association of the Val66Met polymorphism of the brain-derived neurotrophic factor gene with schizophrenia in Russians
    Golimbet, V. E.
    Korovaitseva, G. I.
    Abramova, L. I.
    Kasparov, S. V.
    Uvarova, L. G.
    [J]. MOLECULAR BIOLOGY, 2008, 42 (04) : 531 - 535
  • [23] Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes
    Nedic, Gordana
    Nikolac Perkovic, Matea
    Nenadic Sviglin, Korona
    Muck-Seler, Dorotea
    Borovecki, Fran
    Pivac, Nela
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 193 - 198
  • [24] Decreased Thalamic Volume Correlates with Increased Antidepressant Response to Ketamine in Brain-Derived Neurotrophic Factor (BDNF) rs6265 (val66met) Single Nucleotide Polymorphism Met Carriers
    Niciu, Mark J.
    Iadarola, Nicolas D.
    Luckenbaugh, David A.
    Banerjee, Dipavo
    Richards, Erica M.
    Ballard, Elizabeth D.
    Brutsche, Nancy E.
    McMahon, Francis J.
    Machado-Vieira, Rodrigo
    Nugent, Allison C.
    Zarate, Carlos A.
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 190S - 191S
  • [25] Hippocampal Volumes and the Brain-Derived Neurotrophic Factor val66met Polymorphism in Geriatric Major Depression
    Kanellopoulos, Dora
    Gunning, Faith M.
    Morimoto, Sarah S.
    Hoptman, Matthew J.
    Murphy, Christopher F.
    Kelly, Robert E., Jr.
    Glatt, Charles
    Lim, Kelvin O.
    Alexopoulos, George S.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (01): : 13 - 22
  • [26] Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer
    Yap, Ning Yi
    Tan, Nichole Yue Ting
    Tan, Chia Jie
    Loh, Kiley Wei-Jen
    Ng, Raymond Chee Hui
    Ho, Han Kiat
    Chan, Alexandre
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (03) : 683 - 696
  • [27] The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression
    Hwang, Jen-Ping
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Yang, Chen-Hong
    Lirng, Jiing-Feng
    Yang, Ya-Min
    [J]. NEUROBIOLOGY OF AGING, 2006, 27 (12) : 1834 - 1837
  • [28] Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer
    Ning Yi Yap
    Nichole Yue Ting Tan
    Chia Jie Tan
    Kiley Wei-Jen Loh
    Raymond Chee Hui Ng
    Han Kiat Ho
    Alexandre Chan
    [J]. Breast Cancer Research and Treatment, 2020, 183 : 683 - 696
  • [29] Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients
    Sarchiapone, Marco
    Carli, Vladimir
    Roy, Alec
    Iacoviello, Licia
    Cuomo, Chiara
    Latella, Maria Carmela
    di Giannantonio, Massimo
    Janiri, Luigi
    de Gaetano, Monica
    Janal, Malvin N.
    [J]. NEUROPSYCHOBIOLOGY, 2008, 57 (03) : 139 - 145
  • [30] Association study between the brain-derived neurotrophic factor gene polymorphism (Val66Met) and schizophrenia
    Yui, Naoe
    Shinkai, Takahiro
    Hori, Hiroko
    Ohmori, Osamu
    Matsumoto, Chima
    Nakamura, Jun
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : A32 - A33